JOHN K CLARKE
CIK 1219015 · last filed 2024-05-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.02M
Companies
6
Total Filings
51
Lifetime Open-Market Net
$1.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LIFE | Director | 127,880 | $18.84 | $2.41M | -$72.1K | 16 | 2024-05-23 |
| ALNY | Director | 8,991 | $271.80 | $2.44M | -$1.50M | 12 | 2018-06-22 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 69,123 | — | — | -$766.5K | 11 | 2015-06-11 |
| VSTM | Director | 194,093 | $6.00 | $1.17M | $3.40M | 9 | 2013-06-13 |
| VISICU INC (EICU) Delisted | Director | — | — | — | $0 | 1 | 2007-08-07 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | 1,733,334 | — | — | $0 | 1 | 2007-05-31 |
Recent Filings · Page 5 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-06-04 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2009-06-12 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2009-06-11 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-05 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2008-06-05 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-22 | — | Disp (D) | −3,397,923 | -$40.78M | |
| 2007-08-07 | VISICU INC (EICU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-17 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-15 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-05 | ALNY | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.